ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Centers See Trend To Integrate Control Service With Science

February 18, 1983

FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination

January 31, 2014

NCA Urges Pay Line Adjustment To Cut Back On Grant Duplications

October 10, 1980

Shaw’s Lung Cancer, Bronchoalveolar Carcinoma, Exemplifies Elusiveness of 2015 Goal. Little Known About The Rare Disease.

February 3, 2006

Funding Opportunity: NYC-based Research Alliance Offering $200,000 Per Year for Young Investigators

October 3, 2014

Iressa May Benefit Some Breast Cancer, Studies Find

December 27, 2002